The 142nd Annual Meeting of the Pharmaceutical Society of Japan (Nagoya)

Presentation information

Print

Oral Presentation

(E) Pharmaceutical Health Care and Sciences

[28H-pm] Pharmacotherapies (Cancer)-2

Mon. Mar 28, 2022 2:30 PM - 3:30 PM [Room H] Conference Room 221 (Bldg. 2: 2F)

Chair: Mayako Uchida

2:30 PM - 2:42 PM

[28H-pm06S] Predictive factors and impact of febrile neutropenia with pegfilgrastim treated neoadjuvant chemotherapy of docetaxel, cisplatin and 5-fluorouracil (DCF) for esophageal cancer

○Takahito Inagaki1, Miki Sato2, Masaoki Kin3, Koji Ohtsuka4, Masahiko Murakami4, Mari Kogo2 (1. Grad. Sch. Pharm. Sci., Showa Univ., 2. Div. Pharm., Showa Univ., 3. Pharm., Showa Univ. Hosp. , 4. Esophageal Cancer Center, Showa University)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Password